vs

Side-by-side financial comparison of CHICAGO RIVET & MACHINE CO (CVR) and Foghorn Therapeutics Inc. (FHTX). Click either name above to swap in a different company.

Foghorn Therapeutics Inc. is the larger business by last-quarter revenue ($9.2M vs $6.0M, roughly 1.5× CHICAGO RIVET & MACHINE CO). CHICAGO RIVET & MACHINE CO runs the higher net margin — -19.3% vs -234.3%, a 215.0% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 45.9%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs -12.7%).

Chicago Pneumatic, also known as "CP", is an industrial manufacturer providing power tools, air compressors, generators, light towers and hydraulic equipment. Products are sold in more than 150 countries through a worldwide distribution network. CP is active on markets such as tools for industrial production, vehicle service, maintenance repair operation for mining, construction, infrastructure equipment.

Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.

CVR vs FHTX — Head-to-Head

Bigger by revenue
FHTX
FHTX
1.5× larger
FHTX
$9.2M
$6.0M
CVR
Growing faster (revenue YoY)
FHTX
FHTX
+177.9% gap
FHTX
223.8%
45.9%
CVR
Higher net margin
CVR
CVR
215.0% more per $
CVR
-19.3%
-234.3%
FHTX
Faster 2-yr revenue CAGR
FHTX
FHTX
Annualised
FHTX
35.3%
-12.7%
CVR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CVR
CVR
FHTX
FHTX
Revenue
$6.0M
$9.2M
Net Profit
$-1.2M
$-21.7M
Gross Margin
2.7%
Operating Margin
-15.3%
-258.2%
Net Margin
-19.3%
-234.3%
Revenue YoY
45.9%
223.8%
Net Profit YoY
68.0%
-11.1%
EPS (diluted)
$-0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVR
CVR
FHTX
FHTX
Q4 25
$6.0M
$9.2M
Q3 25
$7.4M
$8.2M
Q2 25
$7.3M
$7.6M
Q1 25
$7.2M
$6.0M
Q4 24
$4.1M
$2.9M
Q3 24
$7.0M
$7.8M
Q2 24
$8.1M
$6.9M
Q1 24
$7.9M
$5.0M
Net Profit
CVR
CVR
FHTX
FHTX
Q4 25
$-1.2M
$-21.7M
Q3 25
$67.6K
$-15.8M
Q2 25
$-395.0K
$-17.9M
Q1 25
$401.0K
$-18.8M
Q4 24
$-3.6M
$-19.5M
Q3 24
$-1.4M
$-19.1M
Q2 24
$142.1K
$-23.0M
Q1 24
$-698.0K
$-25.0M
Gross Margin
CVR
CVR
FHTX
FHTX
Q4 25
2.7%
Q3 25
18.1%
Q2 25
13.4%
Q1 25
22.9%
Q4 24
-43.7%
Q3 24
10.0%
Q2 24
17.6%
Q1 24
9.5%
Operating Margin
CVR
CVR
FHTX
FHTX
Q4 25
-15.3%
-258.2%
Q3 25
0.9%
-226.9%
Q2 25
-5.7%
-279.2%
Q1 25
1.0%
-385.0%
Q4 24
-86.4%
-840.5%
Q3 24
-11.8%
-305.5%
Q2 24
1.3%
-386.6%
Q1 24
-11.5%
-558.3%
Net Margin
CVR
CVR
FHTX
FHTX
Q4 25
-19.3%
-234.3%
Q3 25
0.9%
-194.4%
Q2 25
-5.4%
-237.3%
Q1 25
5.5%
-316.4%
Q4 24
-88.0%
-682.9%
Q3 24
-20.8%
-244.9%
Q2 24
1.8%
-333.6%
Q1 24
-8.9%
-495.4%
EPS (diluted)
CVR
CVR
FHTX
FHTX
Q4 25
$-0.35
Q3 25
$-0.25
Q2 25
$-0.28
Q1 25
$-0.30
Q4 24
$-0.23
Q3 24
$-0.31
Q2 24
$-0.45
Q1 24
$-0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVR
CVR
FHTX
FHTX
Cash + ST InvestmentsLiquidity on hand
$1.7M
$80.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$18.8M
$-108.5M
Total Assets
$23.3M
$198.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVR
CVR
FHTX
FHTX
Q4 25
$1.7M
$80.9M
Q3 25
$1.7M
$89.3M
Q2 25
$1.2M
$72.6M
Q1 25
$765.6K
$61.0M
Q4 24
$2.2M
$55.5M
Q3 24
$2.2M
$57.7M
Q2 24
$2.6M
$138.9M
Q1 24
$2.7M
$79.3M
Total Debt
CVR
CVR
FHTX
FHTX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CVR
CVR
FHTX
FHTX
Q4 25
$18.8M
$-108.5M
Q3 25
$20.0M
$-89.7M
Q2 25
$20.0M
$-76.7M
Q1 25
$20.4M
$-61.7M
Q4 24
$20.0M
$-45.5M
Q3 24
$23.7M
$-28.3M
Q2 24
$25.2M
$-14.3M
Q1 24
$25.2M
$-97.5M
Total Assets
CVR
CVR
FHTX
FHTX
Q4 25
$23.3M
$198.1M
Q3 25
$24.0M
$205.0M
Q2 25
$23.6M
$226.2M
Q1 25
$24.1M
$258.7M
Q4 24
$23.4M
$284.0M
Q3 24
$26.4M
$308.4M
Q2 24
$27.3M
$328.6M
Q1 24
$27.8M
$255.0M
Debt / Equity
CVR
CVR
FHTX
FHTX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVR
CVR
FHTX
FHTX
Operating Cash FlowLast quarter
$116.4K
$-22.3M
Free Cash FlowOCF − Capex
$24.3K
FCF MarginFCF / Revenue
0.4%
Capex IntensityCapex / Revenue
1.5%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-1.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVR
CVR
FHTX
FHTX
Q4 25
$116.4K
$-22.3M
Q3 25
$638.0K
$-18.9M
Q2 25
$28.2K
$-21.0M
Q1 25
$-2.0M
$-24.0M
Q4 24
$-60.1K
$-24.5M
Q3 24
$-58.2K
$-21.0M
Q2 24
$363.5K
$-25.5M
Q1 24
$-398.8K
$-29.3M
Free Cash Flow
CVR
CVR
FHTX
FHTX
Q4 25
$24.3K
Q3 25
$492.1K
Q2 25
$-22.8K
$-21.0M
Q1 25
$-2.1M
$-24.0M
Q4 24
$-118.1K
$-25.0M
Q3 24
$-368.9K
$-21.3M
Q2 24
$58.0K
$-25.6M
Q1 24
$-491.8K
$-29.4M
FCF Margin
CVR
CVR
FHTX
FHTX
Q4 25
0.4%
Q3 25
6.7%
Q2 25
-0.3%
-278.2%
Q1 25
-28.3%
-403.2%
Q4 24
-2.9%
-875.3%
Q3 24
-5.3%
-273.0%
Q2 24
0.7%
-371.0%
Q1 24
-6.3%
-583.1%
Capex Intensity
CVR
CVR
FHTX
FHTX
Q4 25
1.5%
0.0%
Q3 25
2.0%
0.0%
Q2 25
0.7%
0.3%
Q1 25
0.6%
0.5%
Q4 24
1.4%
16.8%
Q3 24
4.5%
4.0%
Q2 24
3.8%
0.2%
Q1 24
1.2%
2.0%
Cash Conversion
CVR
CVR
FHTX
FHTX
Q4 25
Q3 25
9.44×
Q2 25
Q1 25
-5.01×
Q4 24
Q3 24
Q2 24
2.56×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVR
CVR

Fastener$5.1M85%
Other$890.7K15%

FHTX
FHTX

Segment breakdown not available.

Related Comparisons